Table 4.
ID | ST | gyrA | parC | Ciprofloxacin | Nalidixic acid |
---|---|---|---|---|---|
116 | 499/345 | T82S | — | resistant | intermediate |
123C | 499/345 | T82S | — | susceptible | intermediate |
309C | 499/345 | T82S | — | susceptible | susceptible |
43 | 625/860 | S81L | S84L | resistant | resistant |
432B | 625/860 | S81L | S84L | resistant | resistant |
49 | 374/1325 | — | — | susceptible | susceptible |
33 | 979/1848a | — | — | susceptible | susceptible |
363 | 1/405 | S81L | S84L | resistant | resistant |
423 | 1/405 | S81L | S84L | resistant | resistant |
518 | 1/405 | S81L | S84L | resistant | resistant |
558 | 1/405 | S81L | S84L | resistant | resistant |
28 | 2/848 | S81L | S84L | resistant | resistant |
164C | 1232a/1846a | — | — | susceptible | susceptible |
186 | 1233a/1847a | — | — | susceptible | resistant |
—, no relevant substitutions.
Mutations detected in fluoroquinolone resistance-determining regions in A. baumannii. Seven out of 14 A. baumannii isolates were found to possess the mutations S81L in gyrA and S84L in parC.
New STs identified in this study.